DUSA PHARMACEUTICALS INC
Healthcare · Pharmaceutical Preparations · NJ · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY11 | FY10 | |
|---|---|---|
| Revenue | — | — |
| Operating income | $7.8M | $2.7M |
| Net income | $7.3M | $2.7M |
| Total assets | $38.0M | $28.3M |
| Total liabilities | $9.7M | $8.8M |
| Equity | $28.3M | $19.5M |
| EPS (diluted) | $0.28 | $0.11 |
| Shares out. | 24.6M | 24.2M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2011- Operating margin
- —
- Net margin
- —
- Return on equity
- 25.9%
- Return on assets
- 19.3%
- Return on capital (ROCE)
- 24.6%
- Liabilities / assets
- 25.6%
- Debt / equity
- 0.34×
- Book value / share
- $1.15
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- 170.8%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2011- Altman Z″ (distress)
- -1.97distress
- Accruals / assets
- −1.9%clean
- Piotroski F-Score
- 6/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 4 good- Altman Z″ in the distress zone
- Strong return on equity (>15%)
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Unregistered equity sale · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventDec 21, 2012
- Other material eventDec 14, 2012
- Entered a material agreement · Delisting / listing-standard notice · Modified shareholder rights · Other material eventNov 8, 2012
- Other material eventSep 13, 2012
- Shareholder voteJun 15, 2012
- Director / officer changeMay 23, 2012
- Amended charter or bylawsMar 8, 2012
- Entered a material agreementDec 2, 2011
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.